Eton Pharmaceuticals (ETON) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $0.43
- Estimate
- $0.19
- Surprise
- +126.3%
- Revenue (period 2026-06-30)
- $37.6M
- Score at report (before → after)
- 5.9 → 5.8/10
Revenue source: xbrl.
How the report landed
Eton Pharmaceuticals (ETON) beat the $0.19 estimate with diluted EPS of $0.43 — a large 126.3% upside surprise. TrendMatrix's engine moved from Hold (5.9/10) to Sell at 5.8/10 after the report — the engine's score fell despite the beat.
Where TrendMatrix's rating stands now
TrendMatrix currently rates ETON Hold at 6.2/10.
1 of the last 4 quarters beat the estimate; this quarter's +126.3% surprise compares with a +15.4% four-quarter average. Next scheduled report: 2026-11-12.
What supports the rating
- V7 quality resilience bonus: +0.2 (Q=7.8 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Thin upside margin: 7.1%
- Consecutive earnings misses (2)
- Negative momentum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $56.35
- Price target
- $60.35
- Stop
- $52.51
- Upside to target
- +7.1%
- Reward-to-risk
- 0.8:1
The stock trades at 148.5× trailing but 21.3× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-09-17 — shown for context, not personalized investment advice.
ETON at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Drug Manufacturers - Specialty & Generic
- Market cap
- $1.57B
- P/E (fwd)
- 21.3
- P/E (ttm)
- 148.5
- 52-week range
- $14.27–$66.37
- Off 52-week high
- 15.1%
- RSI (14)
- 31
- Volume vs avg
- 0.66×
- Score today
- 6.2/10